高级检索
当前位置: 首页 > 详情页

Lipid emulsion attenuates vasodilation by decreasing intracellular calcium and nitric oxide in vascular endothelial cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Inst Chinese Integrat Med, Dept Pharmacol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Nursing Dept, Shijiazhuang, Peoples R China [3]Hebei Med Univ, Hosp 2, Dept Cardiac Ultrasound, Shijiazhuang, Peoples R China [4]Hebei Gen Hosp, Dept Neurosurg, Shijiazhuang 050000, Hebei, Peoples R China
出处:

关键词: Lipid emulsion Calcium Human endothelial cell Vasodilation Endoplasmic reticulum Nitric oxide

摘要:
Lipid emulsion (LE), a widely used parenteral nutrition, exhibits a well-documented ability to reverse the vasodilatory effects induced by acetylcholine in blood vessels. However, the specific mechanisms underlying this action are not yet fully understood. This study aimed to elucidate the mechanism by which LE reverses vasodilation in vitro through dose-response curve experiments, calcium imaging, and fluorescence assays. The results revealed a significant attenuation of acetylcholine (Ach)-induced vasodilation in rat thoracic aortic rings following LE exposure. In human aortic endothelial cells, pretreatment with LE significantly suppressed ATP-induced calcium elevation. This suppression persisted even after elimination of extracellular calcium with a calcium chelator. Moreover, LE pre-exposure reduced the intracellular calcium concentration ([Ca2+]i) elevation in endothelial cells following cyclopiazonic acid (CPA) treatment, suggesting enhanced endoplasmic reticulum (ER) calcium reuptake. Additionally, nitric oxide (NO) fluorescence assays showed a decrease in NO production upon ATP stimulation post-LE pretreatment of endothelial cells. Taken together, these results indicate that the reversal of vasodilation by LE may involve enhanced ER calcium uptake, leading to a reduction in intracellular calcium concentration and suppression of NO (key vasodilatory agent) synthesis.

基金:
语种:
WOS:
PubmedID:
中科院分区:
出版当年[2025]版:
大类 | 4 区 综合性期刊
小类 | 4 区 综合性期刊
最新[2025]版:
大类 | 4 区 综合性期刊
小类 | 4 区 综合性期刊
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q1 MULTIDISCIPLINARY SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Inst Chinese Integrat Med, Dept Pharmacol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Nursing Dept, Shijiazhuang, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Med Univ, Inst Chinese Integrat Med, Dept Pharmacol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China [4]Hebei Gen Hosp, Dept Neurosurg, Shijiazhuang 050000, Hebei, Peoples R China [*1]Hebei Med Univ, Inst Chinese Integrat Med, Dept Pharmacol Chinese Mat Med, Shijiazhuang 050017, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号